Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients:

Background:The environment surrounding Helicobacter pylorieradication treatment is dramaticallychanging. Recently, vonoprazan, a first-in-class potassium-competitive acid blocker (P-CAB), was int...